⌘K
Loading ticker…
West Pharmaceutical Services, Inc. · Healthcare · Medical Equipment
As of 2026-06-26, West Pharmaceutical Services, Inc. (WST) has a 3-month relative strength percentile of 87 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 62. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 2.3%, relative volume 1.55×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 87, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
WST is in a stage 2 uptrend, week 7. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 12.1% / 28.1%.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
WST is held by 18 ETFs as of Mar 2026. Top owner: VTI at 0.03% weight, $574M notional. Top 3 carry $1.4B.
Top 10 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.03% | $574M |
| VOOVanguard S&P 500 ETF | 0.03% | $458M |
| VOVanguard Mid-Cap ETF | 0.20% | $390M |
| VUGVanguard Growth ETF | 0.08% | $246M |
| IVViShares Core S&P 500 ETF | 0.03% | $232M |
| SPYState Street SPDR S&P 500 ETF | 0.03% | $211M |
| VOTVanguard Mid-Cap Growth ETF | 0.47% | $137M |
| XLVState Street Health Care Select Sector SPDR ETF | 0.34% | $131M |
| IWRiShares Russell Midcap ETF | 0.14% | $69M |
| IWDiShares Russell 1000 Value ETF | 0.06% | $41M |
Showing 10 of 18 ETF owners.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | WST Jan avg: 1.77% median: 5.10% win: 75% σ: 12.41% n: 4 2022-04-12 → 2026-05-29 | WST Feb avg: -1.62% median: 3.06% win: 50% σ: 22.38% n: 4 2022-04-12 → 2026-05-29 | WST Mar avg: 3.65% median: 3.92% win: 50% σ: 7.23% n: 4 2022-04-12 → 2026-05-29 | WST Apr avg: -2.65% median: -5.62% win: 40% σ: 14.98% n: 5 2022-04-12 → 2026-05-29 | WST May avg: -1.58% median: -1.49% win: 20% σ: 6.50% n: 5 2022-04-12 → 2026-05-29 | WST Jun avg: 3.72% median: 1.58% win: 50% σ: 7.54% n: 4 2022-04-12 → 2026-05-29 (current) | WST Jul avg: 3.04% median: 2.79% win: 50% σ: 10.00% n: 4 2022-04-12 → 2026-05-29 | WST Aug avg: 0.64% median: 2.83% win: 75% σ: 10.20% n: 4 2022-04-12 → 2026-05-29 | WST Sep avg: -5.73% median: -6.04% win: 25% σ: 9.62% n: 4 2022-04-12 → 2026-05-29 | WST Oct avg: -2.89% median: -1.95% win: 50% σ: 10.04% n: 4 2022-04-12 → 2026-05-29 | WST Nov avg: 4.06% median: 3.87% win: 75% σ: 5.11% n: 4 2022-04-12 → 2026-05-29 | WST Dec avg: 0.12% median: 0.34% win: 75% σ: 0.60% n: 4 2022-04-12 → 2026-05-29 |